Vaxcyte
Blood & Organ Banks · California, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
825 Industrial Rd Ste 300, San Carlos, C...Phone Number
(650) 837-0111Website
www.vaxcyte.comRevenue
-Stock Symbol
PCVXIndustry
ZI Rank: 15
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
12
11
8
13
22
15
About Vaxcyte
Vaxcyte is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide. The company is headquartered in San Carlos, California.Explore more
Vaxcyte Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vaxcyte your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if Vaxcyte is spiking on competitors!
Click to see if Vaxcyte had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Vaxcyte
Earning: See what the market has to say on Vaxcyte recently announced quarterly report
Product Launch: Get notified when Vaxcyte launches new products
Check if Vaxcyte has recently received funding, and reach out quickly before it becomes old news!
Vaxcyte, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Vaxcyte has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Vaxcyte
Compare insights from companies similar to Vaxcyte, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vaxcyte is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Vaxcyte is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Vaxcyte.
Vaxcyte financials insights
Gather financial insights about Vaxcyte, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Series A
$22M
2017
Series B
$60M
Other Financing Round
$4M
2018
Series C
$85M
2020
Series D
$110M
2022
Stock Offering
$100M
2024
Share Placement
$750M
Vaxcyte Tech Stack
A closer look at the technologies used by Vaxcyte
Most Recent Scoops
Open Position
Hiring Plans
Vaxcyte has more open roles in Medical & Health than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Vaxcyte has more open roles in Finance than it has had at any time in the past 12 months with an increased focus on technologies like Core.
Hiring Plans
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Vaxcyte News & Media
Vaxcyte (PCVX) Completes Enrollment for Phase 3 VAX-31 Clinical Trials
Vaxcyte Inc. (NASDAQ:PCVX) is one of the best mid cap stocks to buy with highest upside potential. On May 6, Vaxcyte achieved a significant milestone by completing enrollment for its three Phase 3 adult clinical trials (OPUS-1, OPUS-2, and OPUS-3) evaluating VAX-31 for the prevention of invasive pneumococcal disease. The OPUS-1 study serves as a […]Vaxcyte, Inc. (PCVX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Vaxcyte, Inc. (PCVX) Bank of America Global Healthcare Conference 2026 May 12, 2026 4:40 PM EDTCompany ParticipantsGrant Pickering - Co-Founder, CEO &...Vaxcyte Reports First Quarter 2026 Financial Results and Provides Business Update
Enrollment Now Completed for OPUS-1, OPUS-2 and OPUS-3 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in AdultsVaxcyte Inc (PCVX)’s VAX-31 Enters Critical Trial Stage
Vaxcyte Inc (NASDAQ:PCVX) is among the best 52-week high US stocks to buy. Vaxcyte Inc (NASDAQ:PCVX) has completed enrollment in a pair of Phase 3 clinical trials evaluating its vaccine candidate VAX-31. The company announced this development on March 23, stating that it enrolled approximately 4,000 participants in the OPUS-1 trial and 1,300 in the […]
Read more news
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vaxcyte
Sign Up For FreeTo access detailed company insights
Vaxcyte is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide. The company is headquartered in San Carlos, California.... Read More
